If you’re asking “What is 21 CFR Part 11?”—here’s the short answer: 21 CFR Part 11 is an FDA regulation that defines how electronic records and electronic signatures must be controlled, protected, and validated in pharmaceutical manufacturing. It sets the rules companies must follow to ensure their digital systems are trustworthy. Understanding it helps teams strengthen compliance, improve data integrity, and streamline operations from audit readiness to batch management.
In this article, you’ll learn what 21 CFR Part 11 means, why it matters, and how it shapes modern OSD (oral solid dosage) production.
Before diving into regulations, it helps to understand what OSD means. OSD (Oral Solid Dosage) refers to solid forms of oral medication, including tablets, capsules, and granules. These dosage forms are popular because they are stable, easy to transport, and cost-effective to produce. Learning how OSD processes work—from granulation to tablet compression—helps readers understand why secure and reliable data systems are crucial in pharmaceutical manufacturing.
21 CFR Part 11 is an FDA regulation that defines the standards for using electronic records and electronic signatures instead of paper-based documentation. It ensures these digital systems are as reliable and authentic as traditional paper documents.
Three Key Takeaways:
In OSD production, such as tablet pressing, coating, and packaging, manufacturers rely heavily on digital systems. Batch management software, equipment automation, online quality checks, and production monitoring all generate sensitive data. Part 11 makes sure this data is trustworthy.
Key Benefits for Pharma
To comply with the FDA rule, manufacturers must implement controls such as:
All software must be tested and documented to show consistent performance. This is a critical part of Equipment Qualification (IQ/OQ).
Every change—regardless of who made it, when, and why—must be recorded automatically.
Signatures must be unique, secure, and tied to authorized personnel only.
Strong passwords, role-based permissions, and secure networks are essential.
Electronic documents must remain accessible for the entire retention period.
These requirements apply across OSD equipment—from tablet presses to coating machines—especially when automated data collection is involved.
Modern OSD production relies on integrated equipment systems for dispensing, granulation, blending, compression, and packaging. To support compliance, manufacturers use tools that automate data collection, record batch parameters, and manage approval workflows. This is where companies like Canaan excel, offering advanced solid dosage equipment designed with automation, traceability, and data integrity in mind.
For example, Canaan’s high-automation systems support validated digital controls, precise batch management, and robust monitoring—helping teams meet 21 CFR Part 11 expectations while improving production efficiency.
Understanding what 21 CFR Part 11 is helps pharmaceutical teams build safer, smarter, and more efficient manufacturing systems. If you’re looking to upgrade your OSD production line, explore Canaan’s collection of advanced equipment designed for automation, reliability, and compliance. Their full OSD solutions support safe, modern manufacturing while aligning with FDA expectations.
If you’re upgrading your lines, explore Canaan’s collection of solid dosage equipment to build a safer and more efficient manufacturing process.
1.Is 21 CFR Part 11 mandatory?
Yes. All pharmaceutical companies using electronic records or signatures must comply.
2.Does Part 11 apply to batch management systems?
Yes. Any system storing critical manufacturing data must meet the requirements of Part 11.
3.How does it support audits?
Audit trails, signatures, and secure records help demonstrate full compliance quickly.
Quick Answer Continuous manufacturing pharmaceutical systems merge blending, granulation, and compression into one unbroken line to meet GMP compliance under 21 CFR Part 11. These lines run in-line, real-time quality monitoring instead of end-of-batch testing, typically handling 5 to 40 kg per hour. Canaan’s integrated pharmaceutical continuous manufacturing lines are built to meet these standards, […]
Quick Answer Cleaning validation in pharmaceutical manufacturing is the documented proof that equipment meets a set residue limit every time. A validated wash runs pre-rinse, detergent wash, rinse, and dry stages under fixed time, temperature, and pressure parameters. Canaan’s QD Series washing stations combine automated washing and drying in one controlled cycle, with key process […]
Quick Answer A CIP system cleans fixed pharmaceutical equipment, such as coating machines and fluid-bed dryers, by circulating water and cleaning solution through the system without disassembly. Programmed pressure, temperature, and cycle times help keep each cleaning run consistent. Canaan uses built-in CIP for fixed equipment and QD Series washing stations for bins and IBCs. […]
+86-577-67378828
canaan@chinacanaan.com